Rongelap 40 NAME HOSPITAL OF THE MEDICAL RESEARCH CENTER, QROOKHAVEN MATIONAL LABORATORY UPTON, NEW YORK 11973 08-45-42R Ares Code 516 YAphank 446262 {UNIT NO.) DISCHARGE SUMMARY time of discharge on June 10th, he was symptom free and his thyroid of normal size. ae “ , . AT the Metropolitan General Hospital thyroid surgery was performed by tos ae " The - cause of this episode is unclear. —_—-— HOSPITALCOURSECONTINUED : = Dr. Brown Dobyns. © 25 ‘mfcrocuries of 131 fodine were given orally the day before for autoradiographic studies of removed thyroid tissues. In surgery a firm area waa noted MEDICATION: Thyroid lobular hyperplasia and hypertrophy with slight fibrosis. — Continued treatment with Lethyroxin (3 MG- a day) is recommended since he is part of the more heavily exposed Rongelap group, § all of whom have been placed on such treatment since 1965. ep Be ar Se : .. rigiee. 1G oS pepe . ee SEs : , . file? 2 Coome~ ” oes i . - 123 - Robert A. Conard, M.D. : vm i ed 7 F a ee ade Mo DIAGWOSTS: -~ *. ote Se: "as ore! the also several areas of nodularity were noted in isthmus. The lower part of the isthmus and part of the right lobe were removed. The pathologist reported the lesions benign with.varying degrees of hyperthrophy, hyperplasia and fibrosis. The patient withstood the surgery well and his convalescence was uneventful. He was discharged on June 18th to return to Che Marshall Islands. Copies of the Hospital Summary and Pathological Reports. from Cleveland incorporated with the BNL records. FT, Oy wee, - at the junction of the right lobe and isthmus which contained several small nodules and